Novacyt (LSE:NCYT) Short Interest


LSE:NCYT Novacyt SA LSE:NCYT
39 GF Score
Price £0.35
GF Value £0.71
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Novacyt Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LSE:NCYT vs ABT, SYK, MDT: Short Interest Comparison

For the Medical Devices subindustry, Novacyt's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novacyt Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Novacyt's Short Interest distribution charts can be found below:

* The bar in red indicates where Novacyt's Short Interest falls into.


LSE:NCYT
39GF Score
Novacyt SA LSE:NCYT
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Novacyt (LSE:NCYT) Overvalued in 2026?

Based on GuruFocus' analysis, Novacyt stock appears to be undervalued. The current stock price of £0.35 is trading 50.3% below its estimated GF Value™ of £0.71. GuruFocus considers Novacyt to be Possible Value Trap.

Key valuation signals for LSE:NCYT:

  • Short Interest:
  • GF Value™: £0.71 vs. price of £0.35 (50.3% below fair value)
  • GF Score™: 39/100 with 4 warning signs

No single metric tells the full story. See the LSE:NCYT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Novacyt Business Description

Address 131 Boulevard Carnot, Le Vesinet, FRA, 78110
Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments: Primer Design, Yourgene Health and Corporate. Majority of the revenue is generated from Yourgene Health segment. Geographically, the company operates in United Kingdom, France, Europe, America, Asia-Pacific, Middle East and Africa generating majority from Asia- pacific region.
39GF Score

Get the complete analysis for LSE:NCYT

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.35
Price
£0.71
GF Value